Form 4: Neuronetics Director Muir Increases Share Ownership

Neuronetics Director Glenn P. Muir acquired 7,554 shares of common stock on October 20, 2025, as part of his non-employee director compensation plan.

Summary

• Glenn P. Muir, a Director of Neuronetics, Inc. (STIM), acquired 7,554 shares of the company's common stock.
• The transaction occurred on October 20, 2025.
• These shares were received as a restricted stock unit (RSU) award that vested immediately upon grant, in lieu of a cash retainer under the Issuer's non-employee directors compensation plan.
• Following this transaction, Muir beneficially owns a total of 371,816 shares of Neuronetics common stock.
• The acquisition price per share was $0, reflecting the nature of the compensation.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even as compensation, generally indicates confidence in the company's future and aligns management interests with shareholders, which is a positive signal.

Positives

• A director increasing their beneficial ownership in the company, even through compensation, can signal confidence in the company's future prospects.
• The election to receive shares instead of cash aligns the director's interests more closely with those of other shareholders.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Insider transactions, such as directors electing to receive equity compensation, are common across industries. Such actions are often viewed by investors as a positive signal, indicating management's belief in the company's long-term value and aligning their interests with shareholders.

Comparison to Industry Standards

• This type of equity compensation for non-employee directors is a standard practice in publicly traded companies, particularly in the medical device and technology sectors.
• It is a common mechanism to attract and retain qualified board members while conserving cash and aligning director incentives with shareholder value.
• Specific comparable companies like TransMedics Group (TMDX) or Inari Medical (NARI) often utilize similar equity-based compensation structures for their non-executive directors.

Related Party Transactions

• The transaction involves a director receiving compensation (shares) from the company, which is a form of related party transaction.

Stakeholder Impact

• Shareholders: May view the director's increased equity stake as a positive sign of confidence in the company's future performance and alignment of interests.

Key Dates

Recommendation

While the director's decision to take equity compensation is a positive signal of alignment and confidence, a single Form 4 filing, especially for compensation, typically does not provide enough fundamental information to warrant a 'buy' or 'sell' recommendation. It reinforces a 'hold' position for existing investors and suggests a positive sentiment for potential investors, but further analysis of financial performance and strategic initiatives would be required for a stronger recommendation.

Keywords

Neuronetics, STIM, Glenn P. Muir, Director, Insider Transaction, Form 4, Common Stock, Share Acquisition, Compensation, Restricted Stock Unit